Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

XERS

Xeris Biopharma Holdings Inc

May 29 • 04:00PM ET

6.16

-0.16 -2.53 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Small • NASD

Peers: AMRX SUPN KNSA ALKS INDV LNTH BHC HRMY TEVA VTRS

| Held by: VTI IWM VXF IWO XPH SCHA VTWO FESM VHT FYC

Scroll to Statements

Index	RUT	P/E	94.05	EPS (ttm)	0.07	Insider Own	3.95%	Shs Outstand	172.56M	Perf Week	-3.45%
Market Cap	1.06B	Forward P/E	16.75	EPS next Y	0.37	Insider Trans	-4.23%	Shs Float	165.83M	Perf Month	2.33%
Enterprise Value	1.21B	PEG	-	EPS next Q	0.01	Inst Own	61.70%	Short Float	7.46%	Perf Quarter	0.65%
Income	12.01M	P/S	3.38	EPS this Y	4425.82%	Inst Trans	2.87%	Short Ratio	7.05	Perf Half Y	-13.24%
Sales	314.85M	P/B	81.70	EPS next Y	153.44%	ROA	3.39%	Short Interest	12.36M	Perf YTD	-21.53%
Book/sh	0.08	P/C	9.52	EPS next 5Y	-	ROE	-	52W High	10.08 -38.89%	Perf Year	22.22%
Cash/sh	0.65	P/FCF	22.38	EPS past 3/5Y	- -	ROIC	4.53%	52W Low	4.30 43.26%	Perf 3Y	133.33%
Dividend Est.	-	EV/EBITDA	24.87	Sales past 3/5Y	38.33% 70.20%	Gross Margin	82.45%	Volatility	4.06% 4.74%	Perf 5Y	97.44%
Dividend TTM	-	EV/Sales	3.84	EPS Y/Y TTM	123.74%	Oper. Margin	11.40%	ATR (14)	0.27	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.50	Sales Y/Y TTM	41.47%	Profit Margin	3.81%	RSI (14)	48.87	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	2.12	EPS Q/Q	120.83%	SMA20	-1.86%	Beta	0.77	Target Price	11.29
Payout	0.00%	Debt/Eq	19.87	Sales Q/Q	38.27%	SMA50	1.93%	Rel Volume	1.10	Prev Close	6.32
Employees	435	LT Debt/Eq	19.39	Earnings	May 07 BMO	SMA200	-13.52%	Avg Volume	1.75M	Price	6.16
IPO	Jun 21, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	470.37% 3.28%	Trades		Volume	1,936,179	Change	-2.53%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)